Item 4 — Purpose of Transaction
Since the filing of Schedule D on November 12, 2024, on January 23, 2025, the Issuer consummated a merger (the "Merger") pursuant to which each issued and outstanding Share was cancelled and converted into the right to receive $45.00 in cash, without interest. In connection with the Merger, the Reporting Persons' 618,018 Shares, which consisted of 156,251 Shares sold for the benefit of Systematic Master Fund, 394,430 Shares sold for the benefit of PRA Master Fund, 35,639 Shares sold for the benefit of the Relative Value Master Fund and 31,698 Shares sold for the benefit of Managed Account, were cancelled and converted into the right to receive $45.00 in cash, without interest.